FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Pfizer, UCB, UK create tech company to speed R&D

Tools

Pfizer and UCB have joined forces to launch Cyclofluidic, which they describe as a "breakthrough technology company established with the aim of significantly accelerating the drug discovery process by allowing researchers to test a greater range of potential new medicines in a shorter time."

The new tech company--which is also being supported by the UK government's Technology Strategy Board--says it will focus on flow chemistry and flow biology.

"Cyclofluidic's entry into the rapidly evolving microfluidic technology area has the potential to radically transform the medicinal chemistry and biology interface," says Dr Neil Weir, senior vice president research at UCB. "It's an exciting opportunity for UCB and Pfizer to collaborate and offers real potential for improved productivity, underlining our commitment to innovation for patients."

- check out the joint release

Related Articles:
UC center wants efficient biotech drug production
Efficient drug programs demand partners, outsourcing
Can Big Pharma effectively develop new drugs?


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Comments (2) | Post a comment
More stories about United Kingdom   UCB   Pfizer   Cyclofluidic   collaborations  

Comments

I know it is still very early to think about jobs at Cyclofluidic. However, I am interested in applying for a post doctoral position with the company. Can anyone advise me about the people I should contact and the possibilities for 2009 ??

I Bet the lions share of the work goes to India
uk won't see a penny that's how it is.

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.